Level Chart

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Orkambi Revenue is at a current level of 63.00M, down from 96.30M last quarter and down from 146.20M one year ago. This is a change of -34.58% from last quarter and -56.91% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 63.00M
Latest Period Sep 2023
Last Updated Jan 31 2024, 08:44 EST
Next Release Apr 30 2024, 08:30 EDT (E)
Average Growth Rate -32.85%
Value from Last Quarter 96.30M
Change from Last Quarter -34.58%
Value from 1 Year Ago 146.20M
Change from 1 Year Ago -56.91%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2023 63.00M
June 30, 2023 96.30M
March 31, 2023 122.50M
December 31, 2022 110.80M
September 30, 2022 146.20M
June 30, 2022 121.60M
March 31, 2022 132.10M
December 31, 2021 147.00M
Date Value
September 30, 2021 185.00M
June 30, 2021 221.00M
March 31, 2021 219.00M
December 31, 2020 215.00M
September 30, 2020 226.00M
June 30, 2020 232.00M
March 31, 2020 234.00M
December 31, 2019 270.00M

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Orkambi Revenue is at a current level of 63.00M, down from 96.30M last quarter and down from 146.20M one year ago. This is a change of -34.58% from last quarter and -56.91% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 63.00M
Latest Period Sep 2023
Last Updated Jan 31 2024, 08:44 EST
Next Release Apr 30 2024, 08:30 EDT (E)
Average Growth Rate -32.85%
Value from Last Quarter 96.30M
Change from Last Quarter -34.58%
Value from 1 Year Ago 146.20M
Change from 1 Year Ago -56.91%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
VRTX Vertex Pharmaceuticals Inc -0.33%